IP Library › Assignment 038609/0312
Patent Assignment
Reel/Frame 038609/0312

Release of Security Interest

Recorded: 2016-05-16 Pages: 7
Assignors
CALIFORNIA CAPITAL EQUITY LLC
Executed: 2016-05-16
NANT CAPITAL LLC
Executed: 2016-05-16
Assignee
EXPRESSION PATHOLOGY INCORPORATED
9620 MEDICAL CENTER DR # 310, ROCKVILLE, MARYLAND, 20850
Covered Properties (45)
Liquid Tissue Preparation From Histopathologically Processed Biological Samples, Tissues and Cells
Patent: 8,455,215 →
Application: 12/348,868 →
Publication: US 2009/0197776
Diagnosis of Diseases and Conditions by Analysis of Histopathologically Processed Biological Samples Using Liquid Tissue Preparations
Patent: 8,609,345 →
Application: 11/915,581 →
Publication: US 2009/0215636
Method of Discovering and Analyzing Secreted Biomarkers of Disease from Solid Tissue
Application: 12/666,288 →
Publication: US 2011/0105337
Biomarkers for Endometrial Disease
Application: 12/937,222 →
Publication: US 2011/0028344
Method of Assessing the Metastatic Status of a Primary Tumor
Application: 12/294,423 →
Publication: US 2009/0263842
Urokinase-Type Plasminogen Activator Protein/Plasminogen Activator Inhibitor Type-1 Protein-Selected Reaction Monitoring Assay
Application: 61/348,712 →
c-Src Selected Reaction Monitoring Assay
Application: 61/369,411 →
Her2 and Truncated p95Her2 SRM/MRM Assay
Application: 61/421,206 →
Truncated HER2 Srm/Mrm Assay
Patent: 9,765,380 →
Application: 13/993,045 →
Publication: US 2013/0302328
Cmet Protein Srm/Mrm Assay
Patent: 9,372,195 →
Application: 13/976,956 →
Publication: US 2014/0005282
Methods for measuring the level of Insulin-Like Growth Factor 1 Receptor (IGF1R) Protein using SRM/MRM Assay
Patent: 8,728,753 →
Application: 13/529,875 →
Publication: US 2012/0302650
Insulin Receptor Substrate 1 (IRS1) Protein SRM/MRM Assay
Patent: 9,417,246 →
Application: 13/529,902 →
Publication: US 2012/0295990
Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM Assay
Patent: 9,733,253 →
Application: 13/529,907 →
Publication: US 2013/0072581
Epidermal Growth Factor Receptor (EGFR) Protein SRM Assay
Application: 13/529,897 →
Publication: US 2013/0011408
cMET Protein SRM/MRM Assay
Application: 61/427,396 →
Protein Biomarkers of Recurrent Breast Cancer
Application: 61/428,145 →
Her3 Protein SRM/MRM Assay
Application: 61/428,147 →
Protein Biomarkers of Late Stage Breast Cancer
Application: 61/428,160 →
Bcl-2-Like Protein 11 SRM/MRM Assay
Application: 61/432,462 →
SRM/MRM Assay for the Fatty Acid Synthase Protein
Application: 61/538,091 →
Multiplex MRM Assay for Evaluation of Cancer
Application: 61/537,918 →
MRM/SRM Assay for Death Receptor 5 Protein
Application: 61/538,096 →
SRM/MRM Assay for the Receptor Tyrosine-Protein Kinase erbB-4 Protein (HER4)
Application: 61/543,092 →
SRM/MRM Assay for the Ephrin Type-A Receptor 2 Protein
Application: 61/543,106 →
Liquid Tissue Preparation from Histopathologically Processed Biological Samples, Tissues and Cells
Patent: 7,473,532 →
Application: 10/796,288 →
Publication: US 2005/0014203
Multiplex Method for Increased Proteomic Coverage from Histopathologically Processed Biological Samples, Tissues Cells
Patent: 7,906,301 →
Application: 11/915,582 →
Publication: US 2009/0136971
Multiplex Liquid Tissue¿ Method for Increased Proteomic Coverage from Histopathologically Processed Biological Samples, Tissues and Cells
Patent: 8,293,485 →
Application: 13/048,522 →
Publication: US 2011/0229917
Liquid Tissue Preparation from Histopathologically Processed Biological Samples, Tissues and Cells
Multiplex Method for Increased Proteomic Coverage from Histopathologically Processed Biological Samples Using Liquid Tissue Preparations
Diagnosis of Deseases and Conditions by Analysis of Histopathologically Processed Biological Samples Using Liquid Tissue Preparations
Method of Discovering and Analyzing Secreted Biomarkers of Disease from Solid Tissue
Biomarkers for Endometrial Disease
Method of Assessing the Metastatic Status of a Primary Tumor
Urokinase-Type Plasminogen Activator Protein/Plasminogen Activator Inhibitor Type-1 Protein-Selected Reaction Monitoring Assay
C-Src Selected Reaction Monitoring Assay
Truncated HER2 Srm/Mrm Assay
Insulin-Like Growth Factor 1 Receptor (Igf-1R) Protein Srm/Mrm Assay
Insulin Receptor Substrate 1 (IRS1) Protein Srm/Mrm Assay
Secreted Protein Acidic and Rich in Cysteine (Sparc) Protein Srm/Mrm Assay
Epidermal Growth Factor Receptor (Egfr) Protein Srm/Mrm Assay
Cmet Protein Srm/Mrm Assay
Protein Biomarkers of Recurrent Breast Cancer
HER3 Protein Srm/Mrm Assay
Protein Biomarkers of Late Stage Breast Cancer
Bcl-2-Like Protein 11 Srm/Mrm Assay
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 12, 2004
From: DARFLER, MARLENE M.; KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 015353/0307 →
Assignment of Assignor's Interest Oct 17, 2008
From: KRIZMAN, DAVID B.; GUIEL, THOMAS G.; DARFLER, MARLENE M.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 021695/0854 →
Assignment of Assignor's Interest Dec 1, 2008
From: KRIZMAN, DAVID B.; GUIEL, THOMAS G.; DARFLER, MARLENE M.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 021905/0743 →
Assignment of Assignor's Interest Mar 24, 2009
From: KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 022471/0836 →
Assignment of Assignor's Interest Aug 9, 2011
From: KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 026722/0301 →
Assignment of Assignor's Interest Dec 8, 2011
From: KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 027350/0050 →
Security Agreement Dec 10, 2012
From: EXPRESSION PATHOLOGY INCORPORATED
To: CALIFORNIA CAPITAL EQUITY LLC; NANT CAPITAL LLC
Reel/Frame 029441/0607 →
Assignment of Assignor's Interest Jun 5, 2014
From: KRIZMAN, DAVID B.; HEMBROUGH, TODD; THYPARAMBIL, SHEENO
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 033043/0195 →
Assignment of Assignor's Interest Jun 6, 2014
From: KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 033051/0097 →
Assignment of Assignor's Interest Jun 30, 2014
From: KRIZMAN, DAVID B.; HEMBROUGH, TODD; THYPARAMBIL, SHEENO; LIAO, WEI-LI
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 033215/0965 →
Assignment of Assignor's Interest Jun 30, 2014
From: KRIZMAN, DAVID B.; LIAO, WEI-LI; THYPARAMBIL, SHEENO; HEMBROUGH, TODD
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 033215/0859 →
Assignment of Assignor's Interest Jun 30, 2014
From: KRIZMAN, DAVID B.; HEMBROUGH, TODD; THYPARAMBIL, SHEENO; LIAO, WEI-LI
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 033215/0984 →
Assignment of Assignor's Interest May 4, 2016
From: EITNER, CASIMIR P.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 038458/0535 →
Assignment of Assignor's Interest May 5, 2016
From: KRIZMAN, DAVID B.; HEMBROUGH, TODD; LIAO, WEI-LI; THYPARAMBIL, SHEENO
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 038482/0366 →
Assignment of Assignor's Interest May 5, 2016
From: KRIZMAN, DAVID B.; THYPARAMBIL, SHEENO; HEMBROUGH, TODD
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 038477/0223 →
Assignment of Assignor's Interest Jul 12, 2017
From: KRIZMAN, DAVID B.; HEMBROUGH, TODD; THYPARAMBIL, SHEENO
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 042982/0071 →
Assignment of Assignor's Interest Apr 10, 2019
From: DARFLER, MARLENE M.; KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 048849/0354 →
Assignment of Assignor's Interest May 10, 2019
From: KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 049136/0710 →